410 related articles for article (PubMed ID: 9013763)
21. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells.
Chapman MS; Askew DJ; Kuscuoglu U; Miesfeld RL
Mol Endocrinol; 1996 Aug; 10(8):967-78. PubMed ID: 8843413
[TBL] [Abstract][Full Text] [Related]
23. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
24. The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer.
Grad JM; Lyons LS; Robins DM; Burnstein KL
Endocrinology; 2001 Mar; 142(3):1107-16. PubMed ID: 11181525
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.
Verrijdt G; Haelens A; Schoenmakers E; Rombauts W; Claessens F
Biochem J; 2002 Jan; 361(Pt 1):97-103. PubMed ID: 11742533
[TBL] [Abstract][Full Text] [Related]
26. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
27. Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation.
Scheller A; Hughes E; Golden KL; Robins DM
J Biol Chem; 1998 Sep; 273(37):24216-22. PubMed ID: 9727045
[TBL] [Abstract][Full Text] [Related]
28. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.
Préfontaine GG; Walther R; Giffin W; Lemieux ME; Pope L; Haché RJ
J Biol Chem; 1999 Sep; 274(38):26713-9. PubMed ID: 10480874
[TBL] [Abstract][Full Text] [Related]
29. The constitution of a progesterone response element.
Lieberman BA; Bona BJ; Edwards DP; Nordeen SK
Mol Endocrinol; 1993 Apr; 7(4):515-27. PubMed ID: 8388996
[TBL] [Abstract][Full Text] [Related]
30. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
[TBL] [Abstract][Full Text] [Related]
31. A conserved carboxy-terminal subdomain is important for ligand interpretation and transactivation by nuclear receptors.
Lanz RB; Rusconi S
Endocrinology; 1994 Nov; 135(5):2183-95. PubMed ID: 7956941
[TBL] [Abstract][Full Text] [Related]
32. Phorbol ester causes ligand-independent activation of the androgen receptor.
Darne C; Veyssiere G; Jean C
Eur J Biochem; 1998 Sep; 256(3):541-9. PubMed ID: 9780230
[TBL] [Abstract][Full Text] [Related]
33. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
34. Deoxyribonucleic acid-binding ability of androgen receptors in whole cells: implications for the actions of androgens and antiandrogens.
Kuil CW; Mulder E
Endocrinology; 1996 May; 137(5):1870-7. PubMed ID: 8612526
[TBL] [Abstract][Full Text] [Related]
35. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.
Vegeto E; Shahbaz MM; Wen DX; Goldman ME; O'Malley BW; McDonnell DP
Mol Endocrinol; 1993 Oct; 7(10):1244-55. PubMed ID: 8264658
[TBL] [Abstract][Full Text] [Related]
36. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states.
Smith CL; Wolford RG; O'Neill TB; Hager GL
Mol Endocrinol; 2000 Jul; 14(7):956-71. PubMed ID: 10894147
[TBL] [Abstract][Full Text] [Related]
37. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
38. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
[TBL] [Abstract][Full Text] [Related]
39. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.
Jenster G; van der Korput HA; van Vroonhoven C; van der Kwast TH; Trapman J; Brinkmann AO
Mol Endocrinol; 1991 Oct; 5(10):1396-404. PubMed ID: 1775129
[TBL] [Abstract][Full Text] [Related]
40. Identification of androgen response elements in mouse mammary tumour virus and the rat prostate C3 gene.
Parker MG; Webb P; Needham M; White R; Ham J
J Cell Biochem; 1987 Dec; 35(4):285-92. PubMed ID: 2831240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
